levofloxacin has been researched along with Ebola Hemorrhagic Fever in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biava, G; Chinello, P; Ippolito, G; Nicastri, E; Petrosillo, N; Pittalis, S | 1 |
1 other study(ies) available for levofloxacin and Ebola Hemorrhagic Fever
| Article | Year |
|---|---|
QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient.
Topics: Adult; Amides; Antiviral Agents; Arrhythmias, Cardiac; Ebolavirus; Electrocardiography; Hemorrhagic Fever, Ebola; Humans; Italy; Levofloxacin; Male; Pyrazines; RNA-Dependent RNA Polymerase; Virus Replication | 2017 |